Posted on 01/09/2025 12:54:41 PM PST by CFW
The medical director of the Texas Medical Board has retired, less than two weeks after conservative lawmakers publicized his employment with a Planned Parenthood laboratory.
Dr. Robert Bredt has worked as medical director for the state medical licensing agency since 2012, earning $185,000 a year. While the members of the licensing board are appointed by Gov. Greg Abbott, the medical director role is hired by agency leadership.
According to his resumé, Bredt also worked at Planned Parenthood South Texas Laboratory since 2011, as well as Genics Laboratory in Las Vegas and San Antonio since 2022. Bredt, 62, is also a professor, consultant and laboratory inspector.
Bredt submitted his retirement paperwork on Tuesday, which was also his last day of work, a medical board spokesperson said in an email. Bredt declined to comment.
This kerfuffle began not with a debate about reproductive health care, but rather, another highly politicized fight about COVID treatments. The Texas Medical Board has been locked in an ongoing legal battle with Dr. Mary Talley Bowden, a Houston ear, nose and throat doctor, about her anti-vaccine stances and use of ivermectin to treat COVID. In 2023, the board filed an official complaint against Bowden, alleging she violated the standard of care, failed to maintain patient-doctor confidentiality and acted unprofessionally by treating a COVID patient without examining them.
(Excerpt) Read more at apnews.com ...
Of course, the media presents the story as Republicans "pounce" or "seize", or "pounce AND seize".
btt
Once you can no longer keep patients alive, you work successfully for planned parenthood, where “Death is the WHOLE POINT!”
“This kerfuffle began not with a debate about reproductive health care,”
Baby killing... a kerfuffle.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.